CSBR Champions Oncology, Inc. Stock Quote

CSBR [NASD]

Index	-	P/E	-	EPS (ttm)	-0.13	Insider Own	5.70%	Shs Outstand	13.06M	Perf Week	3.17%
Market Cap	152.19M	Forward P/E	69.94	EPS next Y	0.16	Insider Trans	-3.97%	Shs Float	10.62M	Perf Month	-0.09%
Income	-1.60M	PEG	-	EPS next Q	0.01	Inst Own	53.80%	Short Float	1.20%	Perf Quarter	21.15%
Sales	37.40M	P/S	4.07	EPS this Y	121.40%	Inst Trans	-1.44%	Short Ratio	3.63	Perf Half Y	14.46%
Book/sh	0.53	P/B	21.51	EPS next Y	443.33%	ROA	-7.40%	Target Price	13.83	Perf Year	38.86%
Cash/sh	0.64	P/C	17.70	EPS next 5Y	15.00%	ROE	-29.90%	52W Range	4.02 - 13.45	Perf YTD	5.65%
Dividend	-	P/FCF	1521.90	EPS past 5Y	40.30%	ROI	-35.80%	52W High	-15.24%	Beta	1.24
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	29.40%	Gross Margin	45.90%	52W Low	183.58%	ATR	0.52
Employees	143	Current Ratio	1.20	Sales Q/Q	32.90%	Oper. Margin	-4.20%	RSI (14)	55.67	Volatility	4.67% 4.26%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	-99.70%	Profit Margin	-4.20%	Rel Volume	0.40	Prev Close	11.27
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Dec 14 AMC	Payout	-	Avg Volume	35.18K	Price	11.40
Recom	2.00	SMA20	3.06%	SMA50	2.24%	SMA200	21.31%	Volume	13,960	Change	1.15%

Nov-18-19

Initiated

The Benchmark Company

Speculative Buy

Jan-19-21 09:00AM	Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics ACCESSWIRE
Jan-05-21 08:30AM	Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic Data and Analytics ACCESSWIRE
Dec-15-20 12:22AM	Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 25%? Simply Wall St.
Dec-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.1 Million ACCESSWIRE
Dec-07-20 04:00PM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020 ACCESSWIRE
Nov-16-20 04:40PM	Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS Program ACCESSWIRE +14.94%
Nov-11-20 09:00AM	Champions Oncology Expands Its Immuno-Oncology Research Offering by Launching a Unique Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform ACCESSWIRE
Oct-31-20 10:08AM	Should You Investigate Champions Oncology, Inc. (NASDAQ:CSBR) At US$8.78? Simply Wall St.
Sep-16-20 07:27AM	Champions Oncology, Inc. Just Beat Revenue Estimates By 11% Simply Wall St.
Sep-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $9.5 Million ACCESSWIRE
Sep-08-20 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 14, 2020 ACCESSWIRE -9.35%
Jul-30-20 07:21AM	Champions Oncology, Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts Simply Wall St.
Jul-27-20 04:01PM	Champions Oncology Reports Quarterly Revenue of $8.8 Million ACCESSWIRE
Jul-22-20 08:00AM	Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 27, 2020 ACCESSWIRE +6.75%
Jul-15-20 03:55PM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? Simply Wall St.
Jun-17-20 09:37AM	The Truth About Market Timing - June 17, 2020 Zacks
May-27-20 07:05AM	If You Had Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago You'd Have Made 278% Simply Wall St.
Apr-28-20 09:50AM	Timing the Market, Is it Possible? - April 28, 2020 Zacks
Apr-27-20 07:20AM	Is Champions Oncology, Inc. (NASDAQ:CSBR) A Volatile Stock? Simply Wall St.
Mar-28-20 09:23AM	Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth Simply Wall St.
Mar-16-20 09:35AM	When Does Market Timing Actually Work? - March 16, 2020 Zacks -14.49%
Mar-12-20 04:17PM	Champions Oncology Reports Record Quarterly Revenue of $9.0 Million ACCESSWIRE -12.71%
Mar-10-20 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020 ACCESSWIRE -6.49%
Feb-26-20 09:32AM	Timing the Market, Is it Possible? - February 26, 2020 Zacks
Feb-18-20 05:44AM	Does Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Pay Reflect Performance? Simply Wall St.
Feb-05-20 09:23AM	When Does Market Timing Actually Work? - February 05, 2020 Zacks
Jan-29-20 09:00AM	The Children's Cancer Therapy Development Institute is collaborating with Champions Oncology and The Jackson Laboratory to provide RACE Act/PREA pediatric cancer study plan services ACCESSWIRE
Jan-17-20 09:34AM	How to Time the Markets Like an Investing Pro - January 17, 2020 Zacks
Jan-13-20 06:07AM	Is There An Opportunity With Champions Oncology, Inc.'s (NASDAQ:CSBR) 42% Undervaluation? Simply Wall St.
Dec-24-19 09:37AM	The Market Timing Secrets No One Talks About - December 24, 2019 Zacks
Dec-16-19 04:00PM	Champions Oncology Reports Quarterly Revenue of $7.6 Million ACCESSWIRE +12.08%
Dec-09-19 08:30AM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 16, 2019 ACCESSWIRE
Dec-08-19 08:59AM	Investors Who Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago Are Now Up 231% Simply Wall St.
Dec-04-19 08:36AM	Simple Market Timing Strategies That Work - December 04, 2019 Zacks +6.54%
Nov-14-19 08:53AM	The Truth About Market Timing - November 14, 2019 Zacks
Nov-13-19 05:00PM	Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-based Phenotypic Assays for Preclinical Drug Development ACCESSWIRE -5.90%
Nov-12-19 07:27AM	What Kind Of Shareholders Own Champions Oncology, Inc. (NASDAQ:CSBR)? Simply Wall St.
Oct-24-19 09:00AM	The Truth About Market Timing - October 24, 2019 Zacks
Oct-18-19 07:41AM	We Think Champions Oncology (NASDAQ:CSBR) Can Easily Afford To Drive Business Growth Simply Wall St.
Oct-03-19 08:49AM	When Does Market Timing Actually Work? - October 03, 2019 Zacks +5.22%
Sep-25-19 12:43PM	What Does Champions Oncology, Inc.'s (NASDAQ:CSBR) Share Price Indicate? Simply Wall St.
Sep-16-19 04:00PM	Champions Oncology Reports Quarterly Revenue of $6.7 Million ACCESSWIRE +14.05%
02:30PM	Champions Oncology, Inc. to Host Earnings Call ACCESSWIRE
Sep-13-19 08:39AM	The Truth About Market Timing - September 13, 2019 Zacks
Sep-09-19 08:30AM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 16, 2019 ACCESSWIRE
Sep-02-19 01:30PM	How Much is Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Getting Paid? Simply Wall St.
Aug-26-19 08:37AM	Yes, You Can Time the Market. Find out How - August 26, 2019 Zacks +5.04%
Aug-05-19 08:42AM	Simple Market Timing Strategies That Work - August 05, 2019 Zacks -7.04%
Jul-29-19 06:48PM	Champions Oncology Inc (CSBR) Files 10-K for the Fiscal Year Ended on April 30, 2019 GuruFocus.com
Jul-26-19 06:58AM	Champions Oncology, Inc. (NASDAQ:CSBR) Delivered A Weaker ROE Than Its Industry Simply Wall St.
Jul-15-19 04:35PM	Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 ACCESSWIRE +12.94%
Jul-12-19 10:00AM	Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 15, 2019 ACCESSWIRE
Jul-02-19 09:35AM	Calculating The Intrinsic Value Of Champions Oncology, Inc. (NASDAQ:CSBR) Simply Wall St.
May-31-19 09:37AM	How Many Champions Oncology, Inc. (NASDAQ:CSBR) Shares Have Insiders Sold, In The Last Year? Simply Wall St.
May-30-19 08:30AM	Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations ACCESSWIRE
May-01-19 08:07AM	What Kind Of Shareholder Owns Most Champions Oncology, Inc. (NASDAQ:CSBR) Stock? Simply Wall St. -5.07%
Apr-17-19 09:49AM	Moving Average Crossover Alert: Champions Oncology Zacks -8.08%
Apr-16-19 10:51AM	New Strong Sell Stocks for April 16th Zacks
Apr-01-19 08:54AM	New Strong Sell Stocks for April 1st Zacks -7.35%
Mar-27-19 10:03AM	New Strong Sell Stocks for March 27th Zacks
Mar-25-19 10:42AM	New Strong Sell Stocks for March 25th Zacks
Mar-18-19 04:00PM	Champions Oncology Reports Quarterly Revenue of $6.4 Million ACCESSWIRE
Mar-06-19 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Monday, March 18, 2019 ACCESSWIRE
Mar-04-19 11:40PM	Champions Oncology (CSBR) Q3 Earnings: What's in Store? Zacks -6.39%
Jan-10-19 08:43AM	Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away? Zacks
Dec-17-18 03:30PM	Champions Oncology Participates in Pre-Clinical Studies to Identify Novel Therapy for Childhood Cancer ACCESSWIRE
03:00PM	Champions Oncology Reports Quarterly Revenue of $6.7 Million ACCESSWIRE
Dec-10-18 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 17, 2018 PR Newswire
Nov-22-18 05:45PM	Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know Zacks
Nov-16-18 05:45PM	Champions Oncology (CSBR) Stock Sinks As Market Gains: What You Should Know Zacks
Nov-15-18 07:20AM	Analysis: Positioning to Benefit within Red Lion Hotels, P.A.M. Transportation Services, Champions Oncology, Kingstone Companies, Applied DNA Sciences, and Innodata Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-07-18 08:30AM	Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select Conference PR Newswire +7.24%
Nov-05-18 05:45PM	Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know Zacks
Nov-02-18 07:27AM	Champions Oncology Sees Hammer Chart Pattern: Time to Buy? Zacks
Oct-29-18 09:30AM	Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year? Zacks -17.93%
Oct-23-18 05:45PM	Champions Oncology (CSBR) Gains As Market Dips: What You Should Know Zacks
Oct-12-18 09:30AM	Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year? Zacks
Oct-04-18 06:55AM	Bull Of The Day: Champions Oncology (CSBR) Zacks +10.65%
Oct-01-18 12:10PM	Best ETFs & Stocks From the Top Sector of Q3 Zacks -17.57%
Sep-28-18 09:15AM	Tech Breaks S&P Out of Slump Zacks
Sep-21-18 10:00AM	Looking for a Top Momentum Pick? Why Champions Oncology (CSBR) is a Great Choice Zacks
Sep-20-18 09:15AM	S&P, Dow Nearing All-Time Highs Zacks -5.51%
Sep-13-18 04:05PM	Champions Oncology Reports Record Quarterly Revenue of $6.2 Million PR Newswire
08:30AM	Champions Oncology to Participate at the Janney Montgomery Scott Healthcare Conference 2018 in New York PR Newswire
Sep-06-18 10:59AM	Champions Oncology (CSBR) Q1 Earnings Preview: How Are Events Shaping Up? Zacks
Aug-28-18 08:30AM	Champions Oncology to Announce First Quarter Financial Results on Thursday, September 13, 2018 PR Newswire
Aug-08-18 08:30AM	Champions Oncology Granted Full Accreditation by the AAALAC PR Newswire
Jul-26-18 04:02PM	Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018 PR Newswire
Jul-12-18 08:30AM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018 PR Newswire
Jun-18-18 08:30AM	Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies PR Newswire +5.88%
May-03-18 08:30AM	Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9th PR Newswire
May-01-18 08:30AM	Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology Research PR Newswire
Apr-04-18 08:30AM	Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House PR Newswire
Mar-28-18 07:10AM	Blog Exposure - Lexicon Announced NDA and MAA Submissions for Sotagliflozin to Treat Adults with Type-1 Diabetes ACCESSWIRE
Mar-15-18 04:01PM	Champions Oncology Reports Quarterly Revenue of $5.1 Million PR Newswire
12:45PM	Champions Oncology, Inc. to Host Earnings Call ACCESSWIRE
08:46AM	Does Champions Oncology Incs (NASDAQ:CSBR) Past Performance Indicate A Stronger Future? Simply Wall St.
Mar-07-18 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018 PR Newswire
Feb-27-18 07:19PM	How Financially Strong Is Champions Oncology Inc (NASDAQ:CSBR)? Simply Wall St.
Feb-26-18 08:30AM	Champions Oncology to Participate at the 30th Annual ROTH Conference PR Newswire

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, the company provides POS products, including TumorGraft implants and drug panels, which utilizes TumorGraft technology to test the response of a patient's tumor to multiple oncology drugs or drug combinations. It markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Breitfeld Philip P.	Director	Dec 16	Sale	11.35	31,443	356,976	0	Dec 17 09:29 AM
TOBIN SCOTT R	Director	Oct 30	Option Exercise	5.46	10,000	54,600	10,000	Oct 30 04:36 PM
SIDRANSKY DAVID	Director	Oct 16	Option Exercise	5.46	16,667	91,002	758,334	Oct 28 02:53 PM
Mendelson Daniel Newman	Director	Mar 26	Buy	5.91	1,220	7,213	58,746	Mar 30 04:56 PM
Mendelson Daniel Newman	Director	Mar 24	Buy	5.50	26	143	57,526	Mar 26 03:00 PM
Morris Ronnie	CEO	Mar 24	Sale	5.25	75	394	837,168	Mar 26 02:52 PM
Morris Ronnie	CEO	Mar 20	Buy	4.75	75	356	837,243	Mar 24 09:54 AM
Morris Ronnie	CEO	Mar 11	Option Exercise	5.74	126,940	728,575	964,108	Nov 03 05:38 PM
New Enterprise Associates 14,	10% Owner	Mar 06	Sale	6.99	708,155	4,950,003	1,713,720	Mar 10 04:45 PM
ACKERMAN JOEL	Director	Mar 03	Option Exercise	5.74	126,940	728,575	1,443,928	Nov 03 05:46 PM
Mendelson Daniel Newman	Director	Feb 18	Option Exercise	3.42	30,000	102,600	123,121	Nov 03 05:44 PM
Mendelson Daniel Newman	Director	Feb 11	Option Exercise	5.76	34,375	198,000	103,121	Nov 03 05:39 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience